{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T17:05:00Z","timestamp":1788368700733,"version":"build-2803163510"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:00:00Z","timestamp":1760918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:00:00Z","timestamp":1760918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Hamburg-Eppendorf (UKE)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Extracellular vesicles (EVs) transport biomolecules that could serve as biomarkers for disease diagnosis and monitoring. The clinical utility of EVs derived from cerebrospinal fluid (CSF) in patients with intradural spinal tumors (IST) has not yet been investigated. Here, we obtained EVs from CSF of adult patients with intraspinal ependymoma (n\u2009=\u20099), meningioma (n\u2009=\u20099), hemangioma (n\u2009=\u20094) and schwannian tumors (n\u2009=\u20097), as well as comparison group (\u2018CG\u2019, normal pressure hydrocephalus, n\u2009=\u20097), by ultrafiltration. CSF-EVs were characterized by electron microscopy and nanoparticle tracking analysis. EV populations according to the presence of tetraspanins (CD9, CD63, CD81) were measured by imaging flow cytometry (IFCM). CD81<jats:sup>+<\/jats:sup> EVs were more prevalent in the comparison group, meningioma, ependymoma WHO grade 2, and hemangioma, whereas CD9<jats:sup>+<\/jats:sup> EVs were predominant in ependymoma grade 1 and Schwannian tumors. CD63<jats:sup>+<\/jats:sup> EVs per milliliter\/CSF differed between ependymoma WHO grades 1 and 2 (FC\u2009=\u200924.6, AUC\u2009=\u200990%, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). Based on results from a bead-based multiplex profiling, we selected ITGB1, CD44, CD133 and HLA-DR\/DQ\/DP for further phenotyping in CSF-EVs using IFCM, in combination with each tetraspanin as double-positive subpopulations. Compared to CG, CD44<jats:sup>+<\/jats:sup> EVs were the most relevant population in CSF from IST patients, followed by ITGB1. Notable differences in absolute (EVs\/mL CSF) and relative (percentages of CSF-EVs) levels were: CD44<jats:sup>+<\/jats:sup>\/CD81<jats:sup>+<\/jats:sup> for ependymoma grade 1 (FC\u2009=\u2009196.5 and 34.5; <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01) and grade 2 (%FC\u2009=\u20096.1, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05); CD44<jats:sup>+<\/jats:sup>\/CD63<jats:sup>+<\/jats:sup> for meningioma (abs. and %FC\u2009&gt;\u20091000, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05); ITGB1<jats:sup>+<\/jats:sup>\/CD81<jats:sup>+<\/jats:sup> for hemangioma (%FC\u2009=\u20094.8, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05); and ITGB1<jats:sup>+<\/jats:sup>\/CD9<jats:sup>+<\/jats:sup> for schwannian tumors (abs.FC\u2009=\u200919.8, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01). In conclusion, we identified distinct EV subpopulations in the CSF of IST patients, potentially facilitating tumor classification.<\/jats:p>","DOI":"10.1038\/s41598-025-23190-w","type":"journal-article","created":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:33:59Z","timestamp":1760956439000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Profiling extracellular vesicles from cerebrospinal fluid for classification of intradural spinal tumors"],"prefix":"10.1038","volume":"15","author":[{"given":"Amanda","family":"Salviano-Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Stevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Mende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolph","family":"Reimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecile L.","family":"Maire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius M.","family":"Mader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lasse","family":"D\u00fchrsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Lamszus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Westphal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven O.","family":"Eicker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz L.","family":"Ricklefs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,20]]},"reference":[{"key":"23190_CR1","doi-asserted-by":"publisher","first-page":"27066","DOI":"10.3402\/jev.v4.27066","volume":"4","author":"M Y\u00e1\u00f1ez-M\u00f3","year":"2015","unstructured":"Y\u00e1\u00f1ez-M\u00f3, M. et al. Biological properties of extracellular vesicles and their physiological functions. J. Extracell. Vesicles 4, 27066 (2015).","journal-title":"J. Extracell. Vesicles"},{"key":"23190_CR2","doi-asserted-by":"publisher","first-page":"eaau6977","DOI":"10.1126\/science.aau6977","volume":"367","author":"R Kalluri","year":"2020","unstructured":"Kalluri, R. & LeBleu, V. S. The biology, function, and biomedical applications of exosomes. Science 367, eaau6977 (2020).","journal-title":"Science"},{"key":"23190_CR3","doi-asserted-by":"publisher","first-page":"e12404","DOI":"10.1002\/jev2.12404","volume":"13","author":"JA Welsh","year":"2024","unstructured":"Welsh, J. A. et al. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches. J. Extracell. Vesicles 13, e12404 (2024).","journal-title":"J. Extracell. Vesicles"},{"key":"23190_CR4","doi-asserted-by":"publisher","first-page":"6709","DOI":"10.1021\/acsami.3c16839","volume":"16","author":"A Onkar","year":"2024","unstructured":"Onkar, A. et al. Smart nanoscale extracellular vesicles in the brain: Unveiling their biology, diagnostic potential, and therapeutic applications. ACS Appl. Mater. Interfaces. 16, 6709\u20136742 (2024).","journal-title":"ACS Appl. Mater. Interfaces."},{"key":"23190_CR5","doi-asserted-by":"publisher","first-page":"1588555","DOI":"10.1080\/20013078.2019.1588555","volume":"8","author":"FL Ricklefs","year":"2019","unstructured":"Ricklefs, F. L. et al. Imaging flow cytometry facilitates multiparametric characterization of extracellular vesicles in malignant brain tumours. J. Extracell. Vesicles 8, 1588555 (2019).","journal-title":"J. Extracell. Vesicles"},{"key":"23190_CR6","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-1941","author":"D Osti","year":"2019","unstructured":"Osti, D. et al. Clinical significance of extracellular vesicles in plasma from glioblastoma patients. Clin. Cancer Res. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-1941 (2019).","journal-title":"Clin. Cancer Res."},{"key":"23190_CR7","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/neuonc\/noac127","volume":"24","author":"FL Ricklefs","year":"2022","unstructured":"Ricklefs, F. L. et al. Diagnostic potential of extracellular vesicles in meningioma patients. Neuro Oncol. 24, 2078\u20132090 (2022).","journal-title":"Neuro Oncol."},{"key":"23190_CR8","doi-asserted-by":"publisher","first-page":"101167","DOI":"10.1016\/j.mam.2022.101167","volume":"91","author":"MN Russo","year":"2023","unstructured":"Russo, M. N., Whaley, L. A., Norton, E. S., Zarco, N. & Guerrero-C\u00e1zares, H. Extracellular vesicles in the glioblastoma microenvironment: A diagnostic and therapeutic perspective. Mol. Aspects Med. 91, 101167 (2023).","journal-title":"Mol. Aspects Med."},{"key":"23190_CR9","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1093\/neuonc\/noae068","volume":"26","author":"FL Ricklefs","year":"2024","unstructured":"Ricklefs, F. L. et al. Circulating extracellular vesicles as biomarker for diagnosis, prognosis, and monitoring in glioblastoma patients. Neuro Oncol. 26, 1280\u20131291 (2024).","journal-title":"Neuro Oncol."},{"key":"23190_CR10","doi-asserted-by":"publisher","first-page":"9844","DOI":"10.1021\/acsnano.4c13599","volume":"19","author":"A Salviano-Silva","year":"2025","unstructured":"Salviano-Silva, A. et al. Extracellular vesicles carrying tenascin-C are clinical biomarkers and improve tumor-derived DNA analysis in glioblastoma patients. ACS Nano 19, 9844\u20139859 (2025).","journal-title":"ACS Nano"},{"key":"23190_CR11","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s10143-018-0957-x","volume":"42","author":"M Ottenhausen","year":"2019","unstructured":"Ottenhausen, M. et al. Intradural spinal tumors in adults\u2014Update on management and outcome. Neurosurg. Rev. 42, 371\u2013388 (2019).","journal-title":"Neurosurg. Rev."},{"key":"23190_CR12","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s12951-023-02051-6","volume":"21","author":"F Zhiguo","year":"2023","unstructured":"Zhiguo, F. et al. A swift expanding trend of extracellular vesicles in spinal cord injury research: A bibliometric analysis. J. Nanobiotechnol. 21, 289 (2023).","journal-title":"J. Nanobiotechnol."},{"key":"23190_CR13","doi-asserted-by":"publisher","first-page":"12218","DOI":"10.1038\/srep12218","volume":"5","author":"E Sand\u00e9n","year":"2015","unstructured":"Sand\u00e9n, E., Eberst\u00e5l, S., Visse, E., Siesj\u00f6, P. & Darabi, A. A standardized and reproducible protocol for serum-free monolayer culturing of primary paediatric brain tumours to be utilized for therapeutic assays. Sci. Rep. 5, 12218 (2015).","journal-title":"Sci. Rep."},{"key":"23190_CR14","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1093\/neuonc\/nop056","volume":"12","author":"L Yu","year":"2010","unstructured":"Yu, L. et al. A clinically relevant orthotopic xenograft model of ependymoma that maintains the genomic signature of the primary tumor and preserves cancer stem cells in vivo. Neuro Oncol. 12, 580\u2013594 (2010).","journal-title":"Neuro Oncol."},{"key":"23190_CR15","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1038\/s41467-023-38044-0","volume":"14","author":"K Okonechnikov","year":"2023","unstructured":"Okonechnikov, K. et al. 3D genome mapping identifies subgroup-specific chromosome conformations and tumor-dependency genes in ependymoma. Nat. Commun. 14, 2300 (2023).","journal-title":"Nat. Commun."},{"key":"23190_CR16","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s00701-012-1577-9","volume":"155","author":"F Salehi","year":"2013","unstructured":"Salehi, F. et al. Proteins involved in regulating bone invasion in skull base meningiomas. Acta Neurochir. 155, 421\u2013427 (2013).","journal-title":"Acta Neurochir."},{"key":"23190_CR17","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.3390\/cells12202483","volume":"12","author":"D Biswas","year":"2023","unstructured":"Biswas, D. et al. Integrated meta-omics analysis unveils the pathways modulating tumorigenesis and proliferation in high-grade meningioma. Cells 12, 2483 (2023).","journal-title":"Cells"},{"key":"23190_CR18","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/biof.5520280307","volume":"28","author":"Y Tao","year":"2006","unstructured":"Tao, Y. et al. Holistic and network analysis of meningioma pathogenesis and malignancy. BioFactors 28, 203\u2013219 (2006).","journal-title":"BioFactors"},{"key":"23190_CR19","doi-asserted-by":"publisher","first-page":"e52707","DOI":"10.1371\/journal.pone.0052707","volume":"7","author":"X Wang","year":"2012","unstructured":"Wang, X. et al. Analysis of gene expression profiling in meningioma: Deregulated signaling pathways associated with meningioma and EGFL6 overexpression in benign meningioma tissue and serum. PLoS ONE 7, e52707 (2012).","journal-title":"PLoS ONE"},{"key":"23190_CR20","first-page":"12621","volume":"8","author":"J Lan","year":"2015","unstructured":"Lan, J. et al. Expression of cancer stem cell markers and their correlation with pathogenesis in vascular tumors. Int. J. Clin. Exp. Pathol. 8, 12621\u201312633 (2015).","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"23190_CR21","first-page":"493","volume":"34","author":"V Martinez-Glez","year":"2009","unstructured":"Martinez-Glez, V. et al. Meningiomas and schwannomas: Molecular subgroup classification found by expression arrays. Int. J. Oncol. 34, 493\u2013504 (2009).","journal-title":"Int. J. Oncol."},{"key":"23190_CR22","doi-asserted-by":"publisher","first-page":"6867","DOI":"10.1038\/s41467-021-27018-9","volume":"12","author":"Q Zhang","year":"2021","unstructured":"Zhang, Q. et al. Interrogation of the microenvironmental landscape in spinal ependymomas reveals dual functions of tumor-associated macrophages. Nat. Commun. 12, 6867 (2021).","journal-title":"Nat. Commun."},{"key":"23190_CR23","doi-asserted-by":"publisher","first-page":"3936","DOI":"10.1038\/s41467-022-31683-9","volume":"13","author":"RG Aubin","year":"2022","unstructured":"Aubin, R. G. et al. Pro-inflammatory cytokines mediate the epithelial-to-mesenchymal-like transition of pediatric posterior fossa ependymoma. Nat. Commun. 13, 3936 (2022).","journal-title":"Nat. Commun."},{"key":"23190_CR24","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2019.10941","author":"B Yang","year":"2019","unstructured":"Yang, B., Dai, J., Pan, Y., Ma, Y. & Chu, S. Identification of biomarkers and construction of a microRNA-mRNA regulatory network for ependymoma using integrated bioinformatics analysis. Oncol. Lett. https:\/\/doi.org\/10.3892\/ol.2019.10941 (2019).","journal-title":"Oncol. Lett."},{"key":"23190_CR25","first-page":"33","volume":"55","author":"I Lewy-Trenda","year":"2004","unstructured":"Lewy-Trenda, I., Omulecka, A., Janczukowicz, J. & Papierz, W. CD44 expression in human meningiomas: An immunohistochemical analysis. Pol. J. Pathol. 55, 33\u201337 (2004).","journal-title":"Pol. J. Pathol."},{"key":"23190_CR26","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2017\/28438.10379","author":"RR Mostafa","year":"2017","unstructured":"Mostafa, R. R. CD44 expression in meningioma and its correlation with proliferation indices. J. Clin. Diagn. Res. https:\/\/doi.org\/10.7860\/JCDR\/2017\/28438.10379 (2017).","journal-title":"J. Clin. Diagn. Res."},{"key":"23190_CR27","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s41984-022-00173-x","volume":"37","author":"AAE Abd Elhakeem","year":"2022","unstructured":"Abd Elhakeem, A. A. E., Essa, A. A., Soliman, R. K. & Hamdan, A. R. K. Novel evaluation of the expression patterns CD44 and MMP9 proteins in intracranial meningiomas and their relationship to the overall survival. Egypt. J. Neurosurg. 37, 33 (2022).","journal-title":"Egypt. J. Neurosurg."},{"key":"23190_CR28","doi-asserted-by":"publisher","first-page":"35811","DOI":"10.1038\/srep35811","volume":"6","author":"S Harbi","year":"2016","unstructured":"Harbi, S. et al. Infantile hemangioma originates from a dysregulated but not fully transformed multipotent stem cell. Sci. Rep. 6, 35811 (2016).","journal-title":"Sci. Rep."},{"key":"23190_CR29","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s10014-018-0323-2","volume":"35","author":"S Takada","year":"2018","unstructured":"Takada, S., Hojo, M., Takebe, N., Tanigaki, K. & Miyamoto, S. Stromal cells of hemangioblastomas exhibit mesenchymal stem cell-derived vascular progenitor cell properties. Brain Tumor Pathol. 35, 193\u2013201 (2018).","journal-title":"Brain Tumor Pathol."},{"key":"23190_CR30","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.1007\/s00432-021-03704-5","volume":"147","author":"M Rehfeld","year":"2021","unstructured":"Rehfeld, M. et al. Differential expression of stem cell markers in proliferating cells in glioma. J. Cancer Res. Clin. Oncol. 147, 2969\u20132982 (2021).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"23190_CR31","doi-asserted-by":"publisher","first-page":"e188","DOI":"10.1016\/j.wneu.2018.12.067","volume":"124","author":"D Kamamoto","year":"2019","unstructured":"Kamamoto, D., Saga, I., Ohara, K., Yoshida, K. & Sasaki, H. Association between CD133, CD44, and nestin expression and prognostic factors in high-grade meningioma. World Neurosurg. 124, e188\u2013e196 (2019).","journal-title":"World Neurosurg."},{"key":"23190_CR32","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1097\/MAO.0b013e31826a540d","volume":"33","author":"D Yi","year":"2012","unstructured":"Yi, D. et al. Activation of PDGFR and EGFR promotes the acquisition of a stem cell-like phenotype in schwannomas. Otol. Neurotol. 33, 1640\u20131647 (2012).","journal-title":"Otol. Neurotol."},{"key":"23190_CR33","doi-asserted-by":"publisher","first-page":"107585","DOI":"10.1016\/j.isci.2023.107585","volume":"26","author":"AM Griesinger","year":"2023","unstructured":"Griesinger, A. M. et al. Multi-omic approach identifies hypoxic tumor-associated myeloid cells that drive immunobiology of high-risk pediatric ependymoma. iScience 26, 107585 (2023).","journal-title":"iScience"},{"key":"23190_CR34","doi-asserted-by":"publisher","first-page":"7428","DOI":"10.4049\/jimmunol.0902811","volume":"183","author":"AM Donson","year":"2009","unstructured":"Donson, A. M. et al. Immune gene and cell enrichment is associated with a good prognosis in ependymoma. J. Immunol. 183, 7428\u20137440 (2009).","journal-title":"J. Immunol."},{"key":"23190_CR35","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1016\/S0002-9440(10)63530-4","volume":"163","author":"A Korshunov","year":"2003","unstructured":"Korshunov, A. et al. Gene expression patterns in ependymomas correlate with tumor location, grade, and patient age. Am. J. Pathol. 163, 1721\u20131727 (2003).","journal-title":"Am. J. Pathol."},{"key":"23190_CR36","doi-asserted-by":"publisher","first-page":"5223","DOI":"10.1200\/JCO.2006.06.3701","volume":"24","author":"P Modena","year":"2006","unstructured":"Modena, P. et al. Identification of tumor-specific molecular signatures in intracranial ependymoma and association with clinical characteristics. J. Clin. Oncol. 24, 5223\u20135233 (2006).","journal-title":"J. Clin. Oncol."},{"key":"23190_CR37","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nrm.2017.125","volume":"19","author":"G van Niel","year":"2018","unstructured":"van Niel, G., D\u2019Angelo, G. & Raposo, G. Shedding light on the cell biology of extracellular vesicles. Nat. Rev. Mol. Cell Biol. 19, 213\u2013228 (2018).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"23190_CR38","doi-asserted-by":"publisher","first-page":"669","DOI":"10.14245\/ns.1938402.201","volume":"16","author":"E Massaad","year":"2019","unstructured":"Massaad, E. et al. Predictive analytics in spine oncology research: First steps, limitations, and future directions. Neurospine 16, 669\u2013677 (2019).","journal-title":"Neurospine"},{"key":"23190_CR39","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.jprot.2014.04.028","volume":"106","author":"D Chiasserini","year":"2014","unstructured":"Chiasserini, D. et al. Proteomic analysis of cerebrospinal fluid extracellular vesicles: A comprehensive dataset. J. Proteomics 106, 191\u2013204 (2014).","journal-title":"J. Proteomics"},{"key":"23190_CR40","doi-asserted-by":"publisher","first-page":"3124","DOI":"10.3390\/ijms25063124","volume":"25","author":"JH Im","year":"2024","unstructured":"Im, J. H. et al. Extracellular vesicles from cerebrospinal fluid of leptomeningeal metastasis patients deliver MiR-21 and induce methotrexate resistance in lung cancer cells. Int. J. Mol. Sci. 25, 3124 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"23190_CR41","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s11910-016-0629-6","volume":"16","author":"ID Connolly","year":"2016","unstructured":"Connolly, I. D., Li, Y., Gephart, M. H. & Nagpal, S. The, \u201cLiquid Biopsy\u201d: the role of circulating DNA and RNA in central nervous system tumors. Curr. Neurol. Neurosci. Rep. 16, 25 (2016).","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"23190_CR42","doi-asserted-by":"publisher","first-page":"2792","DOI":"10.3390\/cancers13112792","volume":"13","author":"A Testa","year":"2021","unstructured":"Testa, A., Venturelli, E. & Brizzi, M. F. Extracellular vesicles as a novel liquid biopsy-based diagnosis for the central nervous system, head and neck, lung, and gastrointestinal cancers: Current and future perspectives. Cancers 13, 2792 (2021).","journal-title":"Cancers"},{"key":"23190_CR43","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1038\/ncb1800","volume":"10","author":"J Skog","year":"2008","unstructured":"Skog, J. et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat. Cell Biol. 10, 1470\u20131476 (2008).","journal-title":"Nat. Cell Biol."},{"key":"23190_CR44","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1038\/nm.2994","volume":"18","author":"H Shao","year":"2012","unstructured":"Shao, H. et al. Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy. Nat. Med. 18, 1835\u20131840 (2012).","journal-title":"Nat. Med."},{"key":"23190_CR45","doi-asserted-by":"publisher","first-page":"1809765","DOI":"10.1080\/20013078.2020.1809765","volume":"9","author":"P Wei","year":"2020","unstructured":"Wei, P. et al. Plasma extracellular vesicles detected by Single Molecule array technology as a liquid biopsy for colorectal cancer. J. Extracell. Vesicles 9, 1809765 (2020).","journal-title":"J. Extracell. Vesicles"},{"key":"23190_CR46","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1016\/j.cell.2023.03.010","volume":"186","author":"R Kalluri","year":"2023","unstructured":"Kalluri, R. & McAndrews, K. M. The role of extracellular vesicles in cancer. Cell 186, 1610\u20131626 (2023).","journal-title":"Cell"},{"key":"23190_CR47","doi-asserted-by":"publisher","first-page":"518","DOI":"10.4081\/oncol.2021.518","volume":"15","author":"A Jahanbakhshi","year":"2021","unstructured":"Jahanbakhshi, A. et al. Adjunctive treatment of myxopapillary ependymoma running head: Myxopapillary ependymoma. Oncol. Rev. 15, 518 (2021).","journal-title":"Oncol. Rev."},{"key":"23190_CR48","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S1470-2045(06)71009-9","volume":"8","author":"DE Traul","year":"2007","unstructured":"Traul, D. E., Shaffrey, M. E. & Schiff, D. Part I: Spinal-cord neoplasms\u2014intradural neoplasms. Lancet Oncol. 8, 35\u201345 (2007).","journal-title":"Lancet Oncol."},{"key":"23190_CR49","first-page":"5141","volume":"11","author":"JL Huang","year":"2021","unstructured":"Huang, J. L., Oshi, M., Endo, I. & Takabe, K. Clinical relevance of stem cell surface markers CD133, CD24, and CD44 in colorectal cancer. Am. J. Cancer Res. 11, 5141\u20135154 (2021).","journal-title":"Am. J. Cancer Res."},{"key":"23190_CR50","doi-asserted-by":"publisher","first-page":"413","DOI":"10.3892\/ol.2023.13999","volume":"26","author":"A Babula","year":"2023","unstructured":"Babula, A., Ga\u0142uszka-Bulaga, A., W\u0119glarczyk, K., Siedlar, M. & Baj-Krzyworzeka, M. CD44-hyaluronan axis plays a role in the interactions between colon cancer-derived extracellular vesicles and human monocytes. Oncol. Lett. 26, 413 (2023).","journal-title":"Oncol. Lett."},{"key":"23190_CR51","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.3390\/ijms22031463","volume":"22","author":"R Szatanek","year":"2021","unstructured":"Szatanek, R. & Baj-Krzyworzeka, M. CD44 and tumor-derived extracellular vesicles (TEVs). Possible gateway to cancer metastasis. Int. J. Mol. Sci. 22, 1463 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"23190_CR52","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12885-021-08870-w","volume":"22","author":"K Ekstr\u00f6m","year":"2022","unstructured":"Ekstr\u00f6m, K. et al. Characterization of surface markers on extracellular vesicles isolated from lymphatic exudate from patients with breast cancer. BMC Cancer 22, 50 (2022).","journal-title":"BMC Cancer"},{"key":"23190_CR53","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.ajoms.2023.08.012","volume":"36","author":"W Hamada","year":"2024","unstructured":"Hamada, W. et al. Tetraspanin CD81 is expressed in human parotid cancer tissue and mediates cell proliferation. J. Oral Maxillofac. Surg. Med. Pathol. 36, 300\u2013307 (2024).","journal-title":"J. Oral Maxillofac. Surg. Med. Pathol."},{"key":"23190_CR54","doi-asserted-by":"publisher","first-page":"e82669","DOI":"10.7554\/eLife.82669","volume":"11","author":"EK Ramos","year":"2022","unstructured":"Ramos, E. K. et al. Machine learning-assisted elucidation of CD81\u2013CD44 interactions in promoting cancer stemness and extracellular vesicle integrity. Elife 11, e82669 (2022).","journal-title":"Elife"},{"key":"23190_CR55","doi-asserted-by":"publisher","first-page":"2947","DOI":"10.1038\/jid.2014.258","volume":"134","author":"A Lupia","year":"2014","unstructured":"Lupia, A. et al. CD63 tetraspanin is a negative driver of epithelial-to-mesenchymal transition in human melanoma cells. J. Investig. Dermatol. 134, 2947\u20132956 (2014).","journal-title":"J. Investig. Dermatol."},{"key":"23190_CR56","doi-asserted-by":"publisher","first-page":"4245","DOI":"10.3892\/ol.2017.6023","volume":"13","author":"X Lai","year":"2017","unstructured":"Lai, X. et al. Decreased expression of CD63 tetraspanin protein predicts elevated malignant potential in human esophageal cancer. Oncol. Lett. 13, 4245\u20134251 (2017).","journal-title":"Oncol. Lett."},{"key":"23190_CR57","doi-asserted-by":"publisher","first-page":"2300078","DOI":"10.1002\/adbi.202300078","volume":"7","author":"S Dey","year":"2023","unstructured":"Dey, S., Basu, S. & Ranjan, A. Revisiting the role of CD63 as pro-tumorigenic or anti-tumorigenic tetraspanin in cancers and its theragnostic implications. Adv. Biol. 7, 2300078 (2023).","journal-title":"Adv. Biol."},{"key":"23190_CR58","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1186\/s12885-024-12472-7","volume":"24","author":"S Liu","year":"2024","unstructured":"Liu, S. et al. CD63 + tumor-associated macrophages drive the progression of hepatocellular carcinoma through the induction of epithelial-mesenchymal transition and lipid reprogramming. BMC Cancer 24, 698 (2024).","journal-title":"BMC Cancer"},{"key":"23190_CR59","doi-asserted-by":"publisher","first-page":"vdz018","DOI":"10.1093\/noajnl\/vdz018","volume":"1","author":"DT Proctor","year":"2019","unstructured":"Proctor, D. T. et al. Tumor-associated macrophage infiltration in meningioma. Neuro-Oncol. Adv. 1, vdz018 (2019).","journal-title":"Neuro-Oncol. Adv."},{"key":"23190_CR60","doi-asserted-by":"publisher","first-page":"1301179","DOI":"10.3389\/fonc.2023.1301179","volume":"13","author":"G Cerretti","year":"2023","unstructured":"Cerretti, G. et al. Spinal ependymoma in adults: From molecular advances to new treatment perspectives. Front. Oncol. 13, 1301179 (2023).","journal-title":"Front. Oncol."},{"key":"23190_CR61","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s00401-023-02668-9","volume":"147","author":"S Neyazi","year":"2024","unstructured":"Neyazi, S. et al. Transcriptomic and epigenetic dissection of spinal ependymoma (SP-EPN) identifies clinically relevant subtypes enriched for tumors with and without NF2 mutation. Acta Neuropathol. 147, 22 (2024).","journal-title":"Acta Neuropathol."},{"key":"23190_CR62","doi-asserted-by":"publisher","first-page":"102046","DOI":"10.1016\/j.tranon.2024.102046","volume":"47","author":"Y Zhou","year":"2024","unstructured":"Zhou, Y. et al. Plasma extracellular vesicles proteomics in meningioma patients. Transl. Oncol. 47, 102046 (2024).","journal-title":"Transl. Oncol."},{"key":"23190_CR63","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s12015-023-10647-6","volume":"20","author":"AP Moreno-Londo\u00f1o","year":"2024","unstructured":"Moreno-Londo\u00f1o, A. P. & Robles-Flores, M. Functional roles of CD133: More than stemness associated factor regulated by the microenvironment. Stem Cell Rev. Rep. 20, 25\u201351 (2024).","journal-title":"Stem Cell Rev. Rep."},{"key":"23190_CR64","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s40169-018-0198-1","volume":"7","author":"PM Glumac","year":"2018","unstructured":"Glumac, P. M. & LeBeau, A. M. The role of CD133 in cancer: A concise review. Clin. Transl. Med. 7, 18 (2018).","journal-title":"Clin. Transl. Med."},{"key":"23190_CR65","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.3390\/cancers14051357","volume":"14","author":"D Brocco","year":"2022","unstructured":"Brocco, D. et al. Blood circulating CD133+ extracellular vesicles predict clinical outcomes in patients with metastatic colorectal cancer. Cancers 14, 1357 (2022).","journal-title":"Cancers"},{"key":"23190_CR66","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nrc2748","volume":"10","author":"JS Desgrosellier","year":"2010","unstructured":"Desgrosellier, J. S. & Cheresh, D. A. Integrins in cancer: Biological implications and therapeutic opportunities. Nat. Rev. Cancer 10, 9\u201322 (2010).","journal-title":"Nat. Rev. Cancer"},{"key":"23190_CR67","doi-asserted-by":"publisher","first-page":"108458","DOI":"10.1016\/j.pharmthera.2023.108458","volume":"247","author":"F Liu","year":"2023","unstructured":"Liu, F., Wu, Q., Dong, Z. & Liu, K. Integrins in cancer: Emerging mechanisms and therapeutic opportunities. Pharmacol. Ther. 247, 108458 (2023).","journal-title":"Pharmacol. Ther."},{"key":"23190_CR68","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.isci.2019.03.022","volume":"14","author":"RM DeRita","year":"2019","unstructured":"DeRita, R. M. et al. Tumor-derived extracellular vesicles require \u03b21 integrins to promote anchorage-independent growth. iScience 14, 199\u2013209 (2019).","journal-title":"iScience"},{"key":"23190_CR69","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s12885-024-11855-0","volume":"24","author":"T Lv","year":"2024","unstructured":"Lv, T. et al. Cancer-associated fibroblast-derived extracellular vesicles promote lymph node metastases in oral cavity squamous cell carcinoma by encapsulating ITGB1 and BMI1. BMC Cancer 24, 113 (2024).","journal-title":"BMC Cancer"},{"key":"23190_CR70","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1186\/s13018-024-04799-5","volume":"19","author":"K Kato","year":"2024","unstructured":"Kato, K., Teferi, N., Challa, M., Eschbacher, K. & Yamaguchi, S. Vertebral hemangiomas: A review on diagnosis and management. J. Orthop. Surg. Res. 19, 310 (2024).","journal-title":"J. Orthop. Surg. Res."},{"key":"23190_CR71","doi-asserted-by":"publisher","first-page":"e37885","DOI":"10.1097\/MD.0000000000037885","volume":"103","author":"L-J Wang","year":"2024","unstructured":"Wang, L.-J., Zou, H.-M., Hou, F., Wang, G.-X. & Gao, C.-P. Aggressive vertebral hemangiomas contain no adipose tissue resulting in thoracic spine kyphosis: A case report. Medicine 103, e37885 (2024).","journal-title":"Medicine"},{"key":"23190_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/3568359","volume":"2017","author":"J Lenzi","year":"2017","unstructured":"Lenzi, J. et al. Spinal nerves schwannomas: Experience on 367 cases\u2014Historic overview on how clinical, radiological, and surgical practices have changed over a course of 60 years. Neurol. Res. Int. 2017, 1\u201312 (2017).","journal-title":"Neurol. Res. Int."},{"key":"23190_CR73","doi-asserted-by":"publisher","first-page":"vdae058","DOI":"10.1093\/noajnl\/vdae058","volume":"6","author":"HTN Nguyen","year":"2024","unstructured":"Nguyen, H. T. N. et al. Matrix metalloproteinase 9: An emerging biomarker for classification of adherent vestibular schwannoma. Neuro-Oncol. Adv. 6, vdae058 (2024).","journal-title":"Neuro-Oncol. Adv."},{"key":"23190_CR74","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nri3818","volume":"15","author":"PA Roche","year":"2015","unstructured":"Roche, P. A. & Furuta, K. The ins and outs of MHC class II-mediated antigen processing and presentation. Nat. Rev. Immunol. 15, 203\u2013216 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"23190_CR75","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1158\/2326-6066.CIR-18-0020","volume":"6","author":"J Qian","year":"2018","unstructured":"Qian, J. et al. TLR2 promotes glioma immune evasion by downregulating MHC class II molecules in microglia. Cancer Immunol. Res. 6, 1220\u20131233 (2018).","journal-title":"Cancer Immunol. Res."},{"key":"23190_CR76","doi-asserted-by":"publisher","first-page":"1569503","DOI":"10.3389\/fimmu.2025.1569503","volume":"16","author":"S Anandan","year":"2025","unstructured":"Anandan, S. et al. Brain-derived blood biomarkers in multiple sclerosis\u2014current trends and beyond. Front. Immunol. 16, 1569503 (2025).","journal-title":"Front. Immunol."},{"key":"23190_CR77","doi-asserted-by":"publisher","first-page":"1235791","DOI":"10.3389\/fimmu.2023.1235791","volume":"14","author":"ML Pleet","year":"2023","unstructured":"Pleet, M. L. et al. Viral Immune signatures from cerebrospinal fluid extracellular vesicles and particles in HAM and other chronic neurological diseases. Front. Immunol. 14, 1235791 (2023).","journal-title":"Front. Immunol."},{"key":"23190_CR78","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3390\/biology14020182","volume":"14","author":"CG Cruz","year":"2025","unstructured":"Cruz, C. G., Sodawalla, H. M., Mohanakumar, T. & Bansal, S. Extracellular vesicles as biomarkers in infectious diseases. Biology 14, 182 (2025).","journal-title":"Biology"},{"key":"23190_CR79","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41586-020-2394-6","volume":"583","author":"L Yang","year":"2020","unstructured":"Yang, L. et al. DNA of neutrophil extracellular traps promotes cancer metastasis via CCDC25. Nature 583, 133\u2013138 (2020).","journal-title":"Nature"},{"key":"23190_CR80","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12987-024-00561-5","volume":"21","author":"A Kamalian","year":"2024","unstructured":"Kamalian, A. et al. Molecular signatures of normal pressure hydrocephalus: A large-scale proteomic analysis of cerebrospinal fluid. Fluids Barr. CNS 21, 64 (2024).","journal-title":"Fluids Barr. CNS"},{"key":"23190_CR81","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.4185","author":"J Van Deun","year":"2017","unstructured":"Van Deun, J. et al. EV-TRACK: Transparent reporting and centralizing knowledge in extracellular vesicle research. Nat. Methods https:\/\/doi.org\/10.1038\/nmeth.4185 (2017).","journal-title":"Nat. Methods"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23190-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23190-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23190-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T12:07:27Z","timestamp":1760962047000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23190-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,20]]},"references-count":81,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["23190"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-23190-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,20]]},"assertion":[{"value":"23 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"36479"}}